In summary, our findings may reveal a novel important mechanism that the patients with certain cancers and chronic diseases could express higher ACE2 expression compared to the individuals without diseases, which may lead to their higher susceptibility to multi‐organ injury of SARS‐CoV‐2 infection. Here, ACE2 is linked to cancer.